Cargando…

Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients—the role of antidiabetic and antihypertensive medications

Recent randomized trials demonstrating the beneficial effects of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in type 2 diabetes suggest that early reductions in eGFR upon initiation of SGLT2i therapy are associated with improved renal outcomes. Multiple concomitant medications, including ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitamura, Koichi, Hayashi, Koichi, Ito, Shinsuke, Hoshina, Yuiko, Sakai, Masahiro, Yoshino, Kaede, Endo, Keita, Fujitani, Shigeki, Suzuki, Toshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099726/ https://www.ncbi.nlm.nih.gov/pubmed/33311577 http://dx.doi.org/10.1038/s41440-020-00590-1

Ejemplares similares

Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study
por: Endo, Keita, et al.
Publicado: (2023)

Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study
por: Sakai, Masahiro, et al.
Publicado: (2023)

Role of a rapid response system and code status discussion as determinants of prognosis for critical inpatients: An observational study in a Japanese urban hospital
por: Higashino, Makoto, et al.
Publicado: (2021)

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation
por: Lentine, Krista L., et al.
Publicado: (2019)

Ultrafiltration in Japanese critically ill patients with acute kidney injury on renal replacement therapy
por: Kitamura, Koichi, et al.
Publicado: (2021)

Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials
por: Cherney, David Z. I., et al.
Publicado: (2021)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
por: Tentolouris, Anastasios, et al.
Publicado: (2019)

Cystacin C-based eGFR and Creatinine Clearance-based eGFR in Patients with Severe Motor and Intellectual Disabilities
por: Tamura, Kouichi, et al.
Publicado: (2023)

Effects of concomitant combination of SGLT‐2 inhibitor and GLP‐1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case series
por: Kuhadiya, Nitesh D., et al.
Publicado: (2021)

Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy
por: Furuichi, Kengo, et al.
Publicado: (2020)

eGFR(cystatinC)/eGFR(creatinine) ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study
por: Avotins, Lauris, et al.
Publicado: (2023)

Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021)

Comparative effectiveness of first-line antihypertensive drug classes on the maintenance of estimated glomerular filtration rate (eGFR) in real world primary care
por: Gao, Qiao, et al.
Publicado: (2023)

SGLT inhibitors as antidiabetic agents: a comprehensive review
por: Kshirsagar, Rahul P., et al.
Publicado: (2020)

Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
por: Dąbrowski, Mariusz
Publicado: (2021)

Point of Care eGFR and the Prediction of Outcomes in Pneumonia
por: Suk, Chi-won, et al.
Publicado: (2019)

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
por: Hirst, Jennifer A, et al.
Publicado: (2018)

Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021)

Unexpected Pleiotropic Effects of SGLT2 Inhibitors: Pearls and Pitfalls of This Novel Antidiabetic Class
por: Kaneto, Hideaki, et al.
Publicado: (2021)

C–H Glycosylation of Native Carboxylic Acids: Discovery of Antidiabetic SGLT-2 Inhibitors
por: Wang, Sanshan, et al.
Publicado: (2023)

Toxicological and Biochemical Analyses of an Autopsy Case Involving Oral Overdose of Multiple Antidiabetic and Antihypertensive Drugs
por: Ikeda, Tomoya, et al.
Publicado: (2018)

Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations
por: Eastwood, John B., et al.
Publicado: (2010)

Anemia is a risk factor for rapid eGFR decline in type 2 diabetes
por: Xie, Lijie, et al.
Publicado: (2023)

Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
por: Jin, Xuguang, et al.
Publicado: (2023)

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE)
por: Caplin, Ben, et al.
Publicado: (2017)

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents
por: Vivian, Eva M
Publicado: (2014)

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
por: Suzuki, Keita, et al.
Publicado: (2022)

Short‐Term Change in eGFR and Risk of Cardiovascular Events
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

Age and the eGFR-dependent risk for adverse clinical outcomes
por: Liu, Ping, et al.
Publicado: (2022)

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR
por: Munch, Philip Vestergaard, et al.
Publicado: (2023)

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
por: Bjornstad, Petter, et al.
Publicado: (2018)

Impaired selective renal filtration captured by eGFR(cysC)/eGFR(crea) ratio is associated with mortality in a population based cohort of older women
por: Malmgren, Linnea, et al.
Publicado: (2022)

SGLT2 Inhibitors and Kidney and Cardiac Outcomes According to Estimated GFR and Albuminuria Levels: A Meta-analysis of Randomized Controlled Trials
por: Chun, Kwang Jin, et al.
Publicado: (2021)

Molecular Modeling Studies of Thiophenyl C-Aryl Glucoside SGLT2 Inhibitors as Potential Antidiabetic Agents
por: Sharma, Mukesh C., et al.
Publicado: (2014)

Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population
por: Nagai, Kei, et al.
Publicado: (2019)

Antidiabetics and antihypertensive medications use in Morocco: A pharmacoepidemiological descriptive study
por: Rida, Elyamani, et al.
Publicado: (2020)

The impact of automated eGFR reporting and education on nephrology service referrals
por: Noble, Euan, et al.
Publicado: (2008)

Renal quality outcomes framework and eGFR: impact on secondary care
por: Phillips, LA, et al.
Publicado: (2012)

Correlation analysis between eGFR(cys) and SXscore in patients with diabetes
por: YONG, ZHONG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2em80titiva8rhk8uoc1ace43a